Darius Lakdawalla

Los Angeles, California, United States Contact Info
2K followers 500+ connections

Join to view profile

About

Dr. Darius Lakdawalla is a health economist, the Quintiles Professor of Pharmaceutical…

Activity

Join now to see all activity

Experience & Education

  • University of Southern California

View Darius’s full experience

See their title, tenure and more.

or

By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.

Publications

  • Careful Use of Science to Advance the Debate on the UK Cancer Drugs Fund

    Journal of the American Medical Association

    Debate continues over the recent renewal of the UK Cancer Drugs Fund. The fund sets aside money for the National Health Service (NHS) to pay for expensive oncology medications that have not been recommended for coverage. In the United Kingdom, the National Institute for Health and Clinical Excellence (NICE) assesses the cost-effectiveness of new therapies and recommends how the NHS should allocate its fixed budget. Since 2010, a total of £1 billion (≈$1.62 billion) has been invested in the…

    Debate continues over the recent renewal of the UK Cancer Drugs Fund. The fund sets aside money for the National Health Service (NHS) to pay for expensive oncology medications that have not been recommended for coverage. In the United Kingdom, the National Institute for Health and Clinical Excellence (NICE) assesses the cost-effectiveness of new therapies and recommends how the NHS should allocate its fixed budget. Since 2010, a total of £1 billion (≈$1.62 billion) has been invested in the fund, which was designed to assuage public concerns over NICE recommendations that blocked or delayed access to some new cancer drugs. The latest investment of £400 million (≈$648 million) means that current and new patients being treated with expensive oncology therapies covered by the fund can draw from it until March 2016. Although drug makers and cancer patient advocacy groups see this as a victory, some health policy researchers and analysts believe that the special cancer fund lacks coherence and fails to support evidence-based decision making.1 The debate over the Cancer Drugs Fund provides an opportunity to reconsider competing issues surrounding the allocation of health care dollars at the end of life.

    Other authors
    See publication

  • How Cancer Patients Value Hope And The Implications For Cost-Effectiveness Assessments Of High-Cost Cancer Therapies

    Health Affairs

    Other authors
    See publication

  • Malpractice Risk According to Physician Specialty

    New England Journal of Medicine

    Other authors
    See publication

  • An Economic Evaluation of the War on Cancer

    Journal of Health Economics

    Other authors

  • US Pharmaceutical Policy in a Global Marketplace

    Health Affairs

    Other authors
    See publication

Honors & Awards

  • Finalist for National Institute of Health Care Management Annual Health Care Research Award

    National Institute of Health Care Management

    Darius Lakdawalla, Eric Sun, Anupam Jena, Carolina Reyes, Dana Goldman, Tomas Philipson. “An economic evaluation of the war on cancer.” Journal of Health Economics 29(3): 333-346.

  • Eugene Garfield Economic Impact Award

    Research America!

    The Garfield Economic Impact Award recognizes outstanding research that illustrates the economic implications of research aimed at improving health or our healthcare system. Established in 2002, this annual award recognizes outstanding research demonstrating the economic impact of medical and health research, including research-based innovations in prevention, disease treatment, and health care delivery.

    Dr. Lakdawalla was awarded this prize for: Lakdawalla, Darius, Dana Goldman…

    The Garfield Economic Impact Award recognizes outstanding research that illustrates the economic implications of research aimed at improving health or our healthcare system. Established in 2002, this annual award recognizes outstanding research demonstrating the economic impact of medical and health research, including research-based innovations in prevention, disease treatment, and health care delivery.

    Dr. Lakdawalla was awarded this prize for: Lakdawalla, Darius, Dana Goldman, Pierre-Carl Michaud, Neeraj Sood, Robert Lempert, Ze Cong, Han de Vries, and Italo Gutierrez. "U.S. Pharmaceutical Policy in a Global Marketplace" Health Affairs , 28, no. 1 (2009): w138-w150.

  • Milken Institute Distinguished Economic Research Prize

    Milken Institute

    The Milken Institute Award for Distinguished Economic Research was created in 1999 to honor the best research in economics, and is open to the academic, business and public policy communities. Entries are judged by the Institute′s professional staff, who look for original, substantive research that coincides with the Institute′s focus on the interaction of social, human and financial capital to help develop innovative means and methods to finance the future. Dr. Lakdawalla received this award…

    The Milken Institute Award for Distinguished Economic Research was created in 1999 to honor the best research in economics, and is open to the academic, business and public policy communities. Entries are judged by the Institute′s professional staff, who look for original, substantive research that coincides with the Institute′s focus on the interaction of social, human and financial capital to help develop innovative means and methods to finance the future. Dr. Lakdawalla received this award for: Lakdawalla, Darius, and Tomas Philipson. "Welfare-Enhancing Technological Change and the Growth of Obesity."

More activity by Darius

View Darius’ full profile

  • See who you know in common
  • Get introduced
  • Contact Darius directly
Join to view full profile

Other similar profiles

Explore collaborative articles

We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.

Explore More

Add new skills with these courses

See all courses